PDCD1 and colorectal carcinoma: To date, three studies have investigated the longitudinal changes of soluble PD-L1 and/or PD-1 during CRC: no changes in PD-1 levels were observed between the measurements before and after neoadjuvant chemoradiotherapy, while PD-L1 increased significantly [13].